Cargando…
Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
BACKGROUND: Combination therapy with deferoxamine and oral deferiprone is superior to deferoxamine alone in removing cardiac iron and improving left ventricular ejection fraction (LVEF). The right ventricle (RV) is also affected by the toxic effects of iron and may cause additional cardiovascular pe...
Autores principales: | Alpendurada, Francisco, Smith, Gill C, Carpenter, John-Paul, Nair, Sunil V, Tanner, Mark A, Banya, Winston, Dessi, Carlo, Galanello, Renzo, Walker, John Malcolm, Pennell, Dudley J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278357/ https://www.ncbi.nlm.nih.gov/pubmed/22277065 http://dx.doi.org/10.1186/1532-429X-14-8 |
Ejemplares similares
-
Effect of deferiprone or deferoxamine on right ventricular function in thalassemia major patients with myocardial iron overload
por: Smith, Gillian C, et al.
Publicado: (2011) -
Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective
por: Galanello, Renzo
Publicado: (2007) -
Right ventricular volumes and function in thalassemia major patients in the absence of myocardial iron overload
por: Carpenter, John-Paul, et al.
Publicado: (2010) -
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction
por: Tanner, Mark A, et al.
Publicado: (2008) -
Cardiac and hepatic iron and ejection fraction in thalassemia major: Multicentre prospective comparison of combined Deferiprone and Deferoxamine therapy against Deferiprone or Deferoxamine Monotherapy
por: Pepe, Alessia, et al.
Publicado: (2013)